184 related articles for article (PubMed ID: 24503571)
41. Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levels.
Hsu MK; Wu IC; Cheng CC; Su JL; Hsieh CH; Lin YS; Chen FC
Oncotarget; 2015 Oct; 6(30):28755-73. PubMed ID: 26356813
[TBL] [Abstract][Full Text] [Related]
42. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
43. Integrated analysis of gene expression and copy number variations in MET proto‑oncogene‑transformed human primary osteoblasts.
Jia RJ; Lan CG; Wang XC; Gao CT
Mol Med Rep; 2018 Feb; 17(2):2543-2548. PubMed ID: 29207108
[TBL] [Abstract][Full Text] [Related]
44. Integrated Analysis of DNA Methylation and mRNA Expression Profiles Data to Identify Key Genes in Lung Adenocarcinoma.
Jin X; Liu X; Li X; Guan Y
Biomed Res Int; 2016; 2016():4369431. PubMed ID: 27610375
[TBL] [Abstract][Full Text] [Related]
45. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
46. Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.
Sudhir PR; Chen CH; Pavana Kumari M; Wang MJ; Tsou CC; Sung TY; Chen JY; Chen CH
Mol Cell Proteomics; 2012 Oct; 11(10):901-15. PubMed ID: 22761399
[TBL] [Abstract][Full Text] [Related]
47. Investigation of Potential Mechanisms Associated with Non-small Cell Lung Cancer.
Shi Y; Zhu S; Yang J; Shao M; Ding W; Jiang W; Sun X; Yao N
J Comput Biol; 2020 Sep; 27(9):1433-1442. PubMed ID: 32048869
[TBL] [Abstract][Full Text] [Related]
48. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
[No Abstract] [Full Text] [Related]
49. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
51. Identification of open chromosomal regions and key genes in prostate cancer via integrated analysis of DNase‑seq and RNA‑seq data.
Wei X; Yu L; Jin X; Song L; Lv Y; Han Y
Mol Med Rep; 2018 Aug; 18(2):2245-2252. PubMed ID: 29956775
[TBL] [Abstract][Full Text] [Related]
52. WISP 1 is an important survival factor in human mesenchymal stromal cells.
Schlegelmilch K; Keller A; Zehe V; Hondke S; Schilling T; Jakob F; Klein-Hitpass L; Schütze N
Gene; 2014 Nov; 551(2):243-54. PubMed ID: 25200494
[TBL] [Abstract][Full Text] [Related]
53. Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma.
Zhang F; Chen X; Wei K; Liu D; Xu X; Zhang X; Shi H
Med Sci Monit; 2017 Jan; 23():172-206. PubMed ID: 28081052
[TBL] [Abstract][Full Text] [Related]
54. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
[TBL] [Abstract][Full Text] [Related]
55. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q
Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966
[TBL] [Abstract][Full Text] [Related]
56. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
[TBL] [Abstract][Full Text] [Related]
57. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
58. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
59. Gene expression profiling by targeted RNA sequencing in pathological stage I lung adenocarcinoma with a solid component.
Kidokoro Y; Sakabe T; Haruki T; Kadonaga T; Nosaka K; Nakamura H; Umekita Y
Lung Cancer; 2020 Sep; 147():56-63. PubMed ID: 32673827
[TBL] [Abstract][Full Text] [Related]
60. Suppression subtractive hybridization identified differentially expressed genes in lung adenocarcinoma: ERGIC3 as a novel lung cancer-related gene.
Wu M; Tu T; Huang Y; Cao Y
BMC Cancer; 2013 Feb; 13():44. PubMed ID: 23374247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
